bluebird bio Files 2024 10-K
| Field | Detail |
|---|---|
| Company | Bluebird Bio, Inc. |
| Form Type | 10-K |
| Filed Date | Mar 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotechnology, financials
TL;DR
bluebird bio filed its 2024 10-K. Check financials.
AI Summary
bluebird bio, Inc. filed its 2024 10-K on March 27, 2025, detailing its financial performance and business operations for the fiscal year ending December 31, 2024. The company, formerly known as Genetix Pharmaceuticals Inc., is focused on biological products. Its principal executive offices are located at 455 Grand Union Boulevard, Somerville, MA.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of bluebird bio's financial health, strategic direction, and potential risks for the past fiscal year.
Risk Assessment
Risk Level: medium — As a biotechnology company, bluebird bio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2023 — Prior Fiscal Year End (For comparison with the current fiscal year's performance.)
- 2022 — Previous Fiscal Year End (For historical financial context.)
Key Players & Entities
- bluebird bio, Inc. (company) — Filer of the 10-K
- Genetix Pharmaceuticals Inc. (company) — Former name of bluebird bio, Inc.
- March 27, 2025 (date) — Filing date of the 10-K
- December 31, 2024 (date) — Fiscal year end
- 455 Grand Union Boulevard, Somerville, MA (location) — Business and mailing address
FAQ
What is the primary business of bluebird bio, Inc.?
bluebird bio, Inc. is primarily involved in the business of Biological Products (NO DIAGNOSTIC SUBSTANCES), as indicated by its SIC code [2836].
When was bluebird bio, Inc. formerly known as?
bluebird bio, Inc. was formerly known as Genetix Pharmaceuticals Inc., with a date of name change on June 16, 2004.
What is the SEC file number for bluebird bio, Inc.'s 10-K filing?
The SEC file number for bluebird bio, Inc.'s 10-K filing is 001-35966.
What is the physical address of bluebird bio, Inc.'s principal executive offices?
The principal executive offices of bluebird bio, Inc. are located at 455 Grand Union Boulevard, Somerville, MA 02145.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 27, 2025 regarding bluebird bio, Inc..